Go Pro

Owlet (OWLT) Competitors

Owlet logo
$5.04 +0.01 (+0.20%)
Closing price 03:59 PM Eastern
Extended Trading
$5.10 +0.05 (+1.09%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

OWLT vs. DCTH, BWAY, TCMD, NPCE, and SGHT

Should you buy Owlet stock or one of its competitors? Owlet's main competitors and comparable companies include Delcath Systems (DCTH), Brainsway (BWAY), Tactile Systems Technology (TCMD), NeuroPace (NPCE), and Sight Sciences (SGHT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Owlet compare to Delcath Systems?

Delcath Systems (NASDAQ:DCTH) and Owlet (NYSE:OWLT) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, media sentiment, risk, profitability, analyst recommendations and dividends.

Delcath Systems has a beta of 0.6, indicating that its stock price is 40% less volatile than the broader market. Comparatively, Owlet has a beta of 1.9, indicating that its stock price is 90% more volatile than the broader market.

61.1% of Delcath Systems shares are owned by institutional investors. Comparatively, 72.6% of Owlet shares are owned by institutional investors. 19.4% of Delcath Systems shares are owned by company insiders. Comparatively, 36.2% of Owlet shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Delcath Systems has a net margin of 0.56% compared to Owlet's net margin of -8.61%. Delcath Systems' return on equity of 0.46% beat Owlet's return on equity.

Company Net Margins Return on Equity Return on Assets
Delcath Systems0.56% 0.46% 0.42%
Owlet -8.61%-601.24%-15.96%

Delcath Systems has higher earnings, but lower revenue than Owlet. Owlet is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Delcath Systems$85.23M6.20$2.70M$0.011,521.80
Owlet$105.70M1.39-$39.68M-$0.75N/A

In the previous week, Delcath Systems had 1 more articles in the media than Owlet. MarketBeat recorded 2 mentions for Delcath Systems and 1 mentions for Owlet. Owlet's average media sentiment score of 1.97 beat Delcath Systems' score of 0.76 indicating that Owlet is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Delcath Systems
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Owlet
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Delcath Systems presently has a consensus target price of $23.17, suggesting a potential upside of 52.23%. Owlet has a consensus target price of $15.00, suggesting a potential upside of 197.91%. Given Owlet's higher possible upside, analysts clearly believe Owlet is more favorable than Delcath Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Delcath Systems
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
3.00
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

Summary

Delcath Systems beats Owlet on 11 of the 17 factors compared between the two stocks.

How does Owlet compare to Brainsway?

Brainsway (NASDAQ:BWAY) and Owlet (NYSE:OWLT) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, media sentiment, valuation, risk, analyst recommendations and institutional ownership.

Brainsway currently has a consensus price target of $18.20, indicating a potential upside of 45.02%. Owlet has a consensus price target of $15.00, indicating a potential upside of 197.91%. Given Owlet's higher possible upside, analysts plainly believe Owlet is more favorable than Brainsway.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Brainsway
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

Brainsway has a beta of 1.29, suggesting that its stock price is 29% more volatile than the broader market. Comparatively, Owlet has a beta of 1.9, suggesting that its stock price is 90% more volatile than the broader market.

Brainsway has a net margin of 15.65% compared to Owlet's net margin of -8.61%. Brainsway's return on equity of 12.74% beat Owlet's return on equity.

Company Net Margins Return on Equity Return on Assets
Brainsway15.65% 12.74% 8.17%
Owlet -8.61%-601.24%-15.96%

Brainsway has higher earnings, but lower revenue than Owlet. Owlet is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Brainsway$52.22M9.66$7.57M$0.4428.52
Owlet$105.70M1.39-$39.68M-$0.75N/A

In the previous week, Brainsway and Brainsway both had 1 articles in the media. Owlet's average media sentiment score of 1.97 beat Brainsway's score of -0.21 indicating that Owlet is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Brainsway
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Owlet
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

30.1% of Brainsway shares are held by institutional investors. Comparatively, 72.6% of Owlet shares are held by institutional investors. 19.0% of Brainsway shares are held by company insiders. Comparatively, 36.2% of Owlet shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Brainsway beats Owlet on 9 of the 15 factors compared between the two stocks.

How does Owlet compare to Tactile Systems Technology?

Owlet (NYSE:OWLT) and Tactile Systems Technology (NASDAQ:TCMD) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, analyst recommendations, media sentiment and institutional ownership.

Tactile Systems Technology has a net margin of 7.10% compared to Owlet's net margin of -8.61%. Tactile Systems Technology's return on equity of 11.49% beat Owlet's return on equity.

Company Net Margins Return on Equity Return on Assets
Owlet-8.61% -601.24% -15.96%
Tactile Systems Technology 7.10%11.49%9.17%

Owlet currently has a consensus target price of $15.00, suggesting a potential upside of 197.91%. Tactile Systems Technology has a consensus target price of $38.40, suggesting a potential upside of 72.97%. Given Owlet's higher probable upside, equities analysts clearly believe Owlet is more favorable than Tactile Systems Technology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Tactile Systems Technology
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67

In the previous week, Tactile Systems Technology had 2 more articles in the media than Owlet. MarketBeat recorded 3 mentions for Tactile Systems Technology and 1 mentions for Owlet. Owlet's average media sentiment score of 1.97 beat Tactile Systems Technology's score of 0.59 indicating that Owlet is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Owlet
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Tactile Systems Technology
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

72.6% of Owlet shares are owned by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are owned by institutional investors. 36.2% of Owlet shares are owned by insiders. Comparatively, 2.1% of Tactile Systems Technology shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Owlet has a beta of 1.9, suggesting that its stock price is 90% more volatile than the broader market. Comparatively, Tactile Systems Technology has a beta of 0.82, suggesting that its stock price is 18% less volatile than the broader market.

Tactile Systems Technology has higher revenue and earnings than Owlet. Owlet is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Owlet$105.70M1.39-$39.68M-$0.75N/A
Tactile Systems Technology$329.52M1.53$19.09M$1.0820.56

Summary

Tactile Systems Technology beats Owlet on 12 of the 16 factors compared between the two stocks.

How does Owlet compare to NeuroPace?

NeuroPace (NASDAQ:NPCE) and Owlet (NYSE:OWLT) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their risk, media sentiment, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

NeuroPace presently has a consensus target price of $19.33, indicating a potential upside of 48.27%. Owlet has a consensus target price of $15.00, indicating a potential upside of 197.91%. Given Owlet's higher possible upside, analysts clearly believe Owlet is more favorable than NeuroPace.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NeuroPace
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.80
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

NeuroPace has a beta of 1.86, indicating that its stock price is 86% more volatile than the broader market. Comparatively, Owlet has a beta of 1.9, indicating that its stock price is 90% more volatile than the broader market.

NeuroPace has higher earnings, but lower revenue than Owlet. NeuroPace is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NeuroPace$99.99M4.48-$21.47M-$0.57N/A
Owlet$105.70M1.39-$39.68M-$0.75N/A

Owlet has a net margin of -8.61% compared to NeuroPace's net margin of -19.34%. NeuroPace's return on equity of -105.64% beat Owlet's return on equity.

Company Net Margins Return on Equity Return on Assets
NeuroPace-19.34% -105.64% -16.51%
Owlet -8.61%-601.24%-15.96%

78.8% of NeuroPace shares are held by institutional investors. Comparatively, 72.6% of Owlet shares are held by institutional investors. 19.2% of NeuroPace shares are held by company insiders. Comparatively, 36.2% of Owlet shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, NeuroPace and NeuroPace both had 1 articles in the media. Owlet's average media sentiment score of 1.97 beat NeuroPace's score of 0.00 indicating that Owlet is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
NeuroPace
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Owlet
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Summary

NeuroPace and Owlet tied by winning 8 of the 16 factors compared between the two stocks.

How does Owlet compare to Sight Sciences?

Owlet (NYSE:OWLT) and Sight Sciences (NASDAQ:SGHT) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, media sentiment, institutional ownership, dividends, valuation and earnings.

Owlet has a net margin of -8.61% compared to Sight Sciences' net margin of -35.69%. Sight Sciences' return on equity of -43.39% beat Owlet's return on equity.

Company Net Margins Return on Equity Return on Assets
Owlet-8.61% -601.24% -15.96%
Sight Sciences -35.69%-43.39%-22.86%

Owlet has a beta of 1.9, meaning that its share price is 90% more volatile than the broader market. Comparatively, Sight Sciences has a beta of 2.45, meaning that its share price is 145% more volatile than the broader market.

In the previous week, Sight Sciences had 2 more articles in the media than Owlet. MarketBeat recorded 3 mentions for Sight Sciences and 1 mentions for Owlet. Owlet's average media sentiment score of 1.97 beat Sight Sciences' score of 0.00 indicating that Owlet is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Owlet
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Sight Sciences
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

72.6% of Owlet shares are held by institutional investors. Comparatively, 55.5% of Sight Sciences shares are held by institutional investors. 36.2% of Owlet shares are held by company insiders. Comparatively, 30.4% of Sight Sciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Sight Sciences has lower revenue, but higher earnings than Owlet. Sight Sciences is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Owlet$105.70M1.39-$39.68M-$0.75N/A
Sight Sciences$77.36M6.17-$38.43M-$0.56N/A

Owlet currently has a consensus price target of $15.00, indicating a potential upside of 197.91%. Sight Sciences has a consensus price target of $7.88, indicating a potential downside of 9.17%. Given Owlet's higher probable upside, research analysts clearly believe Owlet is more favorable than Sight Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Sight Sciences
1 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

Owlet and Sight Sciences tied by winning 8 of the 16 factors compared between the two stocks.

Get Owlet News Delivered to You Automatically

Sign up to receive the latest news and ratings for OWLT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OWLT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OWLT vs. The Competition

MetricOwletHealthcare Equipment & Supplies IndustryHealthcare SectorNYSE Exchange
Market Cap$146.99M$5.48B$7.14B$22.65B
Dividend YieldN/A1.81%2.54%3.73%
P/E Ratio-6.7220.68214.4924.00
Price / Sales1.3967.77607.7521.41
Price / CashN/A32.4377.6038.88
Price / Book7.105.6810.924.64
Net Income-$39.68M$152.11M$3.50B$1.08B
7 Day Performance0.48%-2.01%-2.11%-1.06%
1 Month Performance-0.79%-5.42%-6.34%-5.03%
1 Year Performance-40.37%2.75%8.81%5.78%

Owlet Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OWLT
Owlet
3.1946 of 5 stars
$5.04
+0.2%
$15.00
+197.6%
-39.3%$146.99M$105.70MN/A114
DCTH
Delcath Systems
2.8668 of 5 stars
$16.40
+1.8%
$23.17
+41.3%
+43.3%$559M$85.23M1,641.64156
BWAY
Brainsway
4.701 of 5 stars
$13.63
+0.4%
$18.20
+33.5%
+65.9%$545.62M$52.22M30.98129
TCMD
Tactile Systems Technology
3.7233 of 5 stars
$22.70
-0.7%
$38.40
+69.2%
+57.0%$517.60M$329.52M21.011,086
NPCE
NeuroPace
2.7137 of 5 stars
$14.71
+1.2%
$19.33
+31.4%
+29.7%$499.08M$99.99MN/A220

Related Companies and Tools


This page (NYSE:OWLT) was last updated on 10/2/2026 by MarketBeat.com Staff.
From Our Partners